Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX24 Epinastine
D01713 Epinastine hydrochloride (JAN) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01G DECONGESTANTS AND ANTIALLERGICS
S01GX Other antiallergics
S01GX10 Epinastine
D01713 Epinastine hydrochloride (JAN) <JP/US>
USP drug classification [BR:br08302]
Ophthalmic Agents
Ophthalmic Anti-allergy Agents
Antihistamine
Epinastine
D01713 Epinastine hydrochloride (JAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D01713 Epinastine hydrochloride (JAN)
4 Agents affecting cellular function
44 Allergic agents
449 Miscellaneous
4490 Miscellaneous
D01713 Epinastine hydrochloride (JAN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for otolaryngologic use
69 Oral medicine for nasal inflammation
D01713 Epinastine hydrochloride (JAN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Epinastine
D01713 Epinastine hydrochloride (JAN)
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01116 Epinastine
D01713 Epinastine hydrochloride
Dermatological agent
DG03243 Atopic dermatitis agent
D01713 Epinastine hydrochloride
Drug classes [BR:br08332]
Anti-allergic agent
DG01482 Histamine receptor H1 antagonist
D01713 Epinastine hydrochloride
Dermatological agent
DG03243 Atopic dermatitis agent
D01713 Epinastine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH1
D01713 Epinastine hydrochloride (JAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01713
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01713
Rx-to-OTC switch list in Japan [br08314.html]
D01713
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01116 Epinastine